(Q54627391)

English

Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16341043

Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring. (English)

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16341043

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Aengus O'Marcaigh

5

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16341043

7

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16341043

author name string

Boublikova L

1

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16341043

Kalinova M

2

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16341043

Ryan J

3

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16341043

Quinn F

4

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16341043

Smith O

6

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16341043

Stary J

8

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16341043

McCann SR

9

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16341043

Trka J

10

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16341043

Lawler M

11

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16341043

publication date

1 February 2006

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16341043

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16341043

20

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16341043

254-263

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16341043

2

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16341043

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404047

0 references

Wilms' tumor gene WT1: its oncogenic function and clinical application

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

WT1 proteins: functions in growth and differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

Wilms tumor gene (WT1) expression as a panleukemic marker

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

The complex life of WT1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

Wilms tumor and the WT1 gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

The role of WT1 in oncogenesis: tumor suppressor or oncogene?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

RNA binding by the Wilms tumor suppressor zinc finger proteins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

Identification of WTAP, a novel Wilms' tumour 1-associating protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

Cyclin E is a target of WT1 transcriptional repression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

WT1-p53 interactions in insulin-like growth factor-I receptor gene regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

The Wilms' tumour protein (WT1) shuttles between nucleus and cytoplasm and is present in functional polysomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

Genomic imprinting at the WT1 gene involves a novel coding transcript (AWT1) that shows deregulation in Wilms' tumours.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

An isoform of the Wilms' tumor suppressor gene potentiates granulocytic differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

Wilms tumor gene expression in acute myeloid leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

The possible role and application of WT1 in human leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

WT1 as a universal marker for minimal residual disease detection and quantification in myeloid leukemias and in myelodysplastic syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

Prognostic significance of quantitative analysis of WT1 gene transcripts by competitive reverse transcription polymerase chain reaction in acute leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

Monitoring minimal residual disease in leukemia using real-time quantitative polymerase chain reaction for Wilms tumor gene (WT1).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients - results from a single-centre study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

Minimal residual disease detection after allogeneic stem cell transplantation is correlated to relapse in patients with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

Cancer immunotherapy targeting WT1 protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

Determination of minimal residual disease in leukaemia patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

21 January 2018

WT1: what has the last decade told us?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

7 January 2021

based on heuristic

inferred from DOI database lookup

Transactivation of the WT1 antisense promoter is unique to the WT1[+/−] isoform

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

7 January 2021

based on heuristic

inferred from DOI database lookup

The coexpression of the apoptosis-related genes bcl-2 and wt1 in predicting survival in adult acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

7 January 2021

based on heuristic

inferred from DOI database lookup

Very low frequencies of human normal CD34+ haematopoietic progenitor cells express the Wilms' tumour gene WT1 at levels similar to those in leukaemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

7 January 2021

based on heuristic

inferred from DOI database lookup

Wilms tumor gene (WT1) as a new marker for the detection of minimal residual disease in leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

7 January 2021

based on heuristic

inferred from DOI database lookup

wt1 gene expression in childhood leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

7 January 2021

based on heuristic

inferred from DOI database lookup

wt1 gene expression in childhood acute leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorescent 5'-exonuclease assay for the absolute quantification of Wilms' tumour gene (WT1) mRNA: implications for monitoring human leukaemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

7 January 2021

based on heuristic

inferred from DOI database lookup

Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

7 January 2021

based on heuristic

inferred from DOI database lookup

Wilms' tumour gene (wt1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative real-time RT-PCR detects elevated Wilms tumor gene (WT1) expression in autologous blood stem cell preparations (PBSCs) from acute myeloid leukemia (AML) patients indicating contamination with leukemic blasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

7 January 2021

based on heuristic

inferred from DOI database lookup

Follow-up of minimal residual disease in acute childhood lymphoblastic leukemia by WT1 gene expression in the peripheral blood: the Hungarian experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

7 January 2021

based on heuristic

inferred from DOI database lookup

The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

7 January 2021

based on heuristic

inferred from DOI database lookup

WT1 mRNA in cerebrospinal fluid associated with relapse in pediatric lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

7 January 2021

based on heuristic

inferred from DOI database lookup

Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

7 January 2021

based on heuristic

inferred from DOI database lookup

Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404047

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2404047

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16341043

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16341043

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54627391&oldid=1525900072"